CIK 0001636282
- Large accelerated filer
Spyre Therapeutics, Inc.
Sign in to watch- Ticker
- SYRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464312787
- Phone
- +1 617-651-5940
- Business address
- 221 CRESCENT STREET, BUILDING 23, SUITE 105, WALTHAM, MA, 02453
- Former names
- Aeglea BioTherapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $12,349,597
- in 6 filings, $12.3M under 10b5-1 plans
Net −$12,349,597. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-08-13 | GEORGIOU GEORGE Director | Exercise or conversion | +17,333 | $7.28 | $126K | 155,861 |
| 2018-08-13 | GEORGIOU GEORGE Director | Exercise or conversion | +20,000 | $4.73 | $95K | 175,861 |
| 2018-08-13 | GEORGIOU GEORGE Director | Exercise or conversion · Director Stock Option (right to buy) | −17,333 | 6,667 | ||
| 2018-08-13 | GEORGIOU GEORGE Director | Exercise or conversion · Director Stock Option (right to buy) | −20,000 | 10,000 | ||
| 2018-06-07 | GEORGIOU GEORGE Director | Grant or award · Director Stock Option (right to buy) | +18,400 | 18,400 | ||
| 2017-12-01 | GEORGIOU GEORGE Director | Grant or award · Director Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2016-05-17 | GEORGIOU GEORGE Director | Grant or award · Director Stock Option (right to buy) | +24,000 | 24,000 |
Page 1 of 1 · 7 trades